Article Details
Retrieved on: 2021-06-24 12:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Under the agreement signed with Takara Bio, BioNTech is allowed to use RetroNectin® for production of its cell & gene therapy products, therapies in ...
Article found on: www.pharmiweb.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here